Summary
This review, published in Microbiological Research (2023), examines the emerging evidence for Streptomyces spp. as candidate probiotic organisms, a genus historically associated with antibiotic production rather than human health promotion. The authors likely assess the mechanistic basis for probiotic activity — including enzyme production, pathogen inhibition and immunomodulation — whilst addressing the safety concerns specific to this genus. The paper appears to contribute to a growing body of literature repositioning soil-derived actinobacteria within the context of human gut health and therapeutic microbiology.
UK applicability
Whilst the review is likely international in scope, its findings are broadly applicable to UK researchers and clinicians working on novel probiotics, functional foods, and the gut microbiome, and may have relevance to UK regulatory frameworks governing novel probiotic strains.
Key measures
Probiotic characterisation criteria; antimicrobial activity; gut microbiota modulation; safety and toxicity profiles; bioactive compound production
Outcomes reported
The study likely reviews the probiotic potential of Streptomyces species, examining their antimicrobial, immunomodulatory and gut microbiome-modulating properties, alongside safety and tolerability considerations.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.